TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Vital KSK Holdings, Inc. ( (JP:3151) ) is now available.
Vital KSK Holdings, Inc. has revised its financial forecasts for Fiscal Year 2025, anticipating a decrease in net sales and operating profit due to lower sales in its core pharmaceutical wholesale business and increased research and development expenses. However, the company expects a significant increase in ordinary income from non-operating income, driven by investment returns from the MIJ Healthcare No. 1 Investment Limited Partnership.
The most recent analyst rating on (JP:3151) stock is a Hold with a Yen1340.00 price target. To see the full list of analyst forecasts on Vital KSK Holdings, Inc. stock, see the JP:3151 Stock Forecast page.
More about Vital KSK Holdings, Inc.
Vital KSK Holdings, Inc. operates in the pharmaceutical industry, primarily focusing on pharmaceutical wholesale services. The company is affected by market dynamics such as drug price revisions and competitive bidding, which influence its sales and profitability.
Average Trading Volume: 126,583
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen56.87B
See more insights into 3151 stock on TipRanks’ Stock Analysis page.